欢迎收听今日医学前沿播客!最新研究揭示,针对结直肠癌肝转移患者,90Y放射性节段切除术(RS)的剂量响应可预测局部肿瘤进展。这项研究通过计算SPECT/CT和PET/CT图像中的肿瘤剂量,评估了低体积结直肠癌肝转移(CLM)对RS的反应。研究发现,当肿瘤接受的平均剂量(MTD)≥400Gy,以及周围5mm边缘的平均吸收剂量(MMAD)≥350Gy时,一年内无局部肿瘤进展的生存率达到83.3%,显著高于未达到此剂量的肿瘤。这一发现为结直肠癌肝转移患者的治疗提供了新的剂量指导,有望改善预后。不要错过这一突破性进展,继续关注我们的播客,了解更多详情!
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare
The method of invention, AI's new clock speed and why capital markets are confused
05 Dec 2025
Azeem Azhar's Exponential View